Answer
Agalsidase beta is unlikely to cause cytochrome P450-mediated drug interactions based on its metabolism, although no interaction studies or in vitro metabolism studies have been performed.
Sources for this answer
- Fabrazyme 35mg powder for concentrate for solution for infusionSANOFI · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked